Immucor Attracting Call Buyers (BLUD)

Shares of Immucor, Inc. BLUD are shooting higher mid-day and are currently up by 4.74%, trading at $17.68. Options traders are buying calls on the name today. A short while ago the December $20.00 call was purchased 1,500 times, on the offer, on open interest of only 211 contracts. This was followed by small lot call buying on the November $17.50 and $20.00 strikes Overall call volume is now running at over 13x the daily average, with 90% of all calls traded being purchases on the offer. Immucor, Inc. develops, manufactures and sells a line of reagents and automated systems that detect and identify certain properties of the cell and serum components of human blood for the purpose of blood transfusion. Its offerings are targeted at hospitals, donor centers and reference laboratories.